Trial intelligence / Profile preview

Oxelidine vs sufentanil for intestinal function in ARDS patients

ChiCTR2400086437Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Wannan Medical College
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of oliceridine in acute respiratory distress syndrome (ARDS) (2 arms), sponsored by The First Affiliated Hospital of Wannan Medical College. Primary endpoints: Time to first defecation and Total length of hospital stay. Started Jul 2024; status: recruiting.

02

Drugs

oliceridine
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on ChiCTR2400086437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400086437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call